Results 161 to 170 of about 11,492 (193)

Human Umbilical Cord Mesenchymal Stem Cells in Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) Therapy: Mechanisms, Clinical Efficacy, and Future Perspectives. [PDF]

Stem Cell Rev Rep
Jiang H, Wang H, Zhu Y, Yi C, Liu J, Zhao R, Gao J, Cao A, Guo Y.   +8 more
europepmc   +1 more source

Role of LncSNHG5 in MAFLD: Mechanisms of Arid1a K391 lactylation and lipid accumulation. [PDF]

Clin Transl Med
Li X, Jiang F, Fang B, Lin L, Zheng J, Chen T.   +5 more
europepmc   +1 more source

Construction and Validation of a TyG-ALT-Based Diagnostic Risk-Stratification Model for Metabolic-Associated Fatty Liver Disease in Patients with Obstructive Sleep Apnea. [PDF]

J Clin Med
Wang X, Deng L, Wei Y, Xue Q, Liu M, Zhang J, Wang J.   +6 more
europepmc   +1 more source

Exploring racial-specific associations between the food inflammation index(FII) and metabolic dysfunction-associated fatty liver disease (MAFLD) Prevalence: Data from the National Health and Nutrition Examination Survey 1999-2020. [PDF]

Medicine (Baltimore)
Wang S, Wang Y, Peng H, Wang J, Chen E.
europepmc   +1 more source

Association of frailty and metabolism with multi-state model in fatty liver disease, diabetes mellitus and all-cause mortality. [PDF]

Diabetol Metab Syndr
Wang X, Jin C, Zhong Q, Wang X, Xu Y, Li M, Liu L, Huang H, Liang A, Wang J, Wu X, Li L, Zou M.   +12 more
europepmc   +1 more source

Hepatogenomics of MAFLD in Asian Population: Genetic Polymorphisms and Pathway-Based Insights. [PDF]

Diabetes Metab Syndr Obes
Justyn M, Sutanto C, Barliana MI, Heryaman H, Meiliana A, Puspitasari IM.   +5 more
europepmc   +1 more source

[Natural history and risk factors of metabolic associated fatty liver disease in Chinese cohorts]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Zhang J, Zhan RX, Wang Y, Nan YM.
europepmc   +1 more source

Metabolic dysfunction-associated fatty liver disease in chronic hepatitis B: dual effects on hepatocarcinogenesis and evolving strategies for risk prediction. [PDF]

Front Immunol
Tao H, Duan Y, Yu G, Yan W, Yin J.
europepmc   +1 more source

Ginsenosides for the Management of Metabolic Dysfunction-Associated Fatty Liver Disease: A Research Update. [PDF]

Nutrients
Zhang K, Qin Z, Guo Q, Lu J, Luo H, Zha L.   +5 more
europepmc   +1 more source

[Mesenchymal stem cell-derived exosomes: a new hope for metabolic-associated fatty liver disease]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Zhou D, Gao XQ, Zhang LT.
europepmc   +1 more source